Quickfire Q&A delivers in-person insights from congress, bringing expert perspectives on the studies and data shaping clinical practice.
In this episode, recorded at the American Society of Clinical Oncology (ASCO) Annual Meeting 2026, we speak to Pooja Advani, Assistant Professor of Medicine and Consultant, Mayo Clinic, Jacksonville, Florida, USA, about the breast cancer data poised to influence clinical practice and the wider themes shaping oncology care.
Key topics discussed include:
- OPTIMA: Could genomic testing help identify patients with early breast cancer who can safely avoid chemotherapy?
- Trials to watch: The latest findings from lidERA, KEYNOTE-522, I-SPY, ASCENT-04, SERENA-6, and VIKTORIA-1.
- Personalized cancer care: How circulating tumor DNA and other tools could support disease monitoring and more tailored treatment.
- The wider cancer journey: Growing attention to symptom management, lifestyle, early detection, survivorship, and barriers to accessing care.
Read the latest issue of AMJ Oncology for more expert insights and highlights from ASCO 2026.
